Article

Antibiotics May Increase Heart Disease Risk in Older Women

Author(s):

Gut microbiota alternations have been linked to a variety of life-threatening disorders.

According to preliminary research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018, women who take antibiotics for long periods, especially in late adulthood, have an increased risk of death from heart disease and in general. It’s been known that antibiotic use is associated with long-lasting changes in gut microbiota however, until this study, researchers have yet to assess relatively health populations in order to determine how duration of antibiotic use at different times in adulthood may relate to all-cause and cause-specific risk of death.

“Gut microbiota alternations have been associated with a variety of life-threatening disorders, such as cardiovascular diseases and certain types of cancer,” Lu Qi, MD, PhD, professor of epidemiology, Tulane University, said in a statement.

To further examine this, researchers from Tulane University School of Public Health and Tropical Medicine and Harvard T.H. Chan School of Public Health studied 37,510 women, aged 60 years and older, who reported antibiotic use and were free of heart disease and cancer at the study’s start. Women were classified into 4 groups based on the length of time antibiotics were used; not at all, less than 15 days, 15 days to less than 2 months, or 2 or more months. Researchers followed the study population for 8 years, from 2004 until June 2012.

Click to continue reading on MD Magazine.

Related Videos
Image Credit: © Birdland - stock.adobe.com
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Hurricane Helene, Baxter plant, IV fluids shortage, health systems impact, injectable medicines, compounding solutions, patient care errors, clinical resources, operational consideration, fluid conservation, sterile water, temperature excursions, training considerations, patient safety, feedback request
Image Credit: © Andrey Popov - stock.adobe.com